Skip to main content
SIU School of Medicine Logo

Domain Menu

  • Patient Care
  • School of Medicine

Main Menu Edu Secondary

  • faculty
  • intranet
  • library
  • news & events
  • donate
  • careers
I am a...
  • Patient
  • Donor or Friend
  • Prospective Employee
  • Student/Prospective Student
  • Resident or Fellow
  • Alumni

Main Menu Edu

Main Menu Close
Main Menu
  • Degree Programs
  • Research
  • Academic & Clinical Departments
  • Centers & Institutes
  • Community Programs
    • Equity, Diversity and Inclusion
    • External Relations
    • Family and Community Medicine
    • Office of Community Care
    • Office of Correctional Medicine
    • Population Science and Policy
    • Rural Health and Social Service Development
  • About Us
    • Administrative offices
    • Careers
    • Why SIU School of Medicine
      • Strategic plan
      • A Model for Medical Education
      • Facts and figures
      • Our campuses
    • Economic Impact Report (pdf)
    • History
      • Notable alumni
      • Points of pride
      • Timeline
    • Leadership
      • SIU Medicine Board of Directors
      • SIU School of Medicine Leadership
    • News and Events
Search Site close Close

Breadcrumb

  1. Home
  2. Trials and Research Search
clinical trials

Clinical trials and research studies

At SIU Medicine, our researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.
Enroll today
search
Reset

Filter Results

Activity Status

  • Active, not recruiting (5)
  • Active, recruiting (12)

Treatment

  • (-) Epilepsy (9)
  • (-) High Blood Pressure (Hypertension) (8)
  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (4)
  • Autism Spectrum Disorder (1)
  • Breast Cancer (3)
  • Cervical Cancer (1)
  • Depression (1)
  • Diseases of the Lungs (2)
  • Endometrial Cancer (1)
  • Endometriosis (1)
  • Erectile Dysfunction (ED) (1)
  • Heart Disease (2)
  • Leukemia (1)
  • Male Infertility (1)
  • Melanoma (1)
  • Myeloma (1)
  • Neuro-Critical Care (1)
  • Ovarian Cancer (4)
  • Parkinson's Disease (1)
  • Psoriasis (1)
  • Stroke (3)
  • Transcranial Magnetic Stimulation (TMS) (1)
  • Vascular Disease (1)

Department

  • Cardiology (1)
  • Internal Medicine (4)
  • Neurology (4)
Reset

Filter Results

Activity Status

  • Active, not recruiting (5)
  • Active, recruiting (12)

Treatment

  • (-) Epilepsy (9)
  • (-) High Blood Pressure (Hypertension) (8)
  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (4)
  • Autism Spectrum Disorder (1)
  • Breast Cancer (3)
  • Cervical Cancer (1)
  • Depression (1)
  • Diseases of the Lungs (2)
  • Endometrial Cancer (1)
  • Endometriosis (1)
  • Erectile Dysfunction (ED) (1)
  • Heart Disease (2)
  • Leukemia (1)
  • Male Infertility (1)
  • Melanoma (1)
  • Myeloma (1)
  • Neuro-Critical Care (1)
  • Ovarian Cancer (4)
  • Parkinson's Disease (1)
  • Psoriasis (1)
  • Stroke (3)
  • Transcranial Magnetic Stimulation (TMS) (1)
  • Vascular Disease (1)

Department

  • Cardiology (1)
  • Internal Medicine (4)
  • Neurology (4)
Showing: 17 Results
search
Trial
Neurology

Renaissance 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

Active recruiting

To evaluate the efficacy of SPN-817 as a treatment for adult participants with focal onset seizures.

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Trial
Neurology

Supernus Renaissance 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

Active recruiting

To evaluate the efficacy of SPN-817 as a treatment for adult participants with focal onset seizures.

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Trial
Cardiology

The "RADIANCE II" Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

Active not recruiting
The purpose of this clinical study is to see whether a medical device called the Paradise Renal Denervation System (also called The Paradise System) can lower high blood pressure in patients who are known to have hypertension
Contact: Emily Starkey phone217-545-7616 emailestarkey74@siumed.edu
Trial
Internal Medicine

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension

Active recruiting

The purpose of this clinical trial is to assess whether a medical device called the TIVUS System can lower high blood pressure in patients who are known to have hypertension. 

Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or currently taking anti-hypertensive medications.

Contact: Katy Martz phone217-545-4342 emailkmartz35@siumed.edu
Trial
Neurology

UCB EP0162: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Active recruiting

The purpose of this study is to compare the success of a single admnistration of Staccato alprazolam compar

Contact: Rylee Manka phone217-545-1394 emailrmanka63@siumed.edu
Trial
Neurology

Xenon XPF-010-302: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Active recruiting

The primary objective of this study is to assess the effect of XEN1101 versus placebo on reducing focal sei

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Trial
Neurology

Xenon XPF-010-303: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Active recruiting

The primary objective is to assess the effect of XEN1101 versus placebo on reducing PGTCS frequency in subj

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Go back to search filters

Pagination

  • Previous page ‹‹
  • Page 1
  • Current page 2

This browser is no longer supported and some key features will not work. We strongly recommend using Edge, Chrome 70+, Safari 5.x+ and Firefox 5.x+.

SIU School of Medicine Logo
© 2025 SIU Board of Trustees all rights reserved

Legal

  • Equal Opportunity Employer
  • Nondiscrimination Statement
  • Privacy Policy
  • FOIA
  • ADA

About Us

  • About Us
  • Contact
  • SIU Intranet
  • SIU Medicine
  • Southern Illinois University Carbondale
  • Southern Illinois University Edwardsville
  • Southern Illinois University System

Social

  • Facebook
  • Twitter
  • Youtube
  • Instagram